Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FY8BL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,396
Award facts
- Contract value 100% obligated
- $31,395.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Dupixent 300 mg/2 mL pen injections with a ceiling value of $31,395.87. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award. The order is scheduled for ultimate completion on November 4, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic asthma, and other inflammatory conditions, making this a critical pharmaceutical supply for military and veteran healthcare systems.
This delivery order represents one of numerous pharmaceutical procurements issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a prime vendor agreement valued at $999.99 million through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical product deliveries and has demonstrated consistent capability to fulfill competitive federal procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FY8BL?
SPE2DR26FY8BL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26FY8BL worth?
The government has obligated $31,396 on SPE2DR26FY8BL.
Is contract SPE2DR26FY8BL an order under another contract?
Yes. SPE2DR26FY8BL is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8BL competed?
The extent of competition for SPE2DR26FY8BL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award